Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Al Khaboori, Jabber"'
The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective
Autor:
Alroughani, Raed, VAN WIJMEERSCH, Bart, Al Khaboori, Jabber, Alsharoqi, Isa Ahmed, Ahmed, Samar F., Hassan, Ali, Inshasi, Jihad, Krieger, Derk W., Shakra, Mustafa, Shatila, Ahmed Osman, Szolics, Miklos, Khallaf, Mohamed, Ezzat, Aly
Over the past decade, the development of high-efficacy disease-modifying therapies (DMTs) has been responsible for more effective management of relapsing-remitting multiple sclerosis (RRMS). However, the gaps in optimal care for this complex disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______105::1920e9c04d73d0735ba7757d8af8f245
http://hdl.handle.net/1942/32888
http://hdl.handle.net/1942/32888
Autor:
Alroughani R; Division of Neurology, Department of Medicine, Al Amiri Hospital, Kuwait., Van Wijmeersch B; Universiteit Hasselt and Rehabilitation & MS-Centre Pelt, Belgium., Al Khaboori J; Khoula Hospital, Mina Al Fahal, Muscat, Oman., Alsharoqi IA; Salmaniya Medical Complex, Bahrain., Ahmed SF; Ibn Sina Hospital, Kuwait., Hassan A; Tawam Hospital, Al Ain, Abu Dhabi, United Arab Emirates., Inshasi J; Rashid Hospital, Dubai, United Arab Emirates., Krieger DW; Mediclinic Hospital, Dubai, United Arab Emirates., Shakra M; Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates., Shatila AO; Al Mafraq Hospital, Abu Dhabi, United Arab Emirates., Szolics M; Tawam Hospital, Al Ain, Abu Dhabi, United Arab Emirates., Khallaf M; Sanofi Genzyme, Dubai, United Arab Emirates., Ezzat A; Sanofi Genzyme, Dubai, United Arab Emirates.
Publikováno v:
Therapeutic advances in neurological disorders [Ther Adv Neurol Disord] 2020 Sep 16; Vol. 13, pp. 1756286420954119. Date of Electronic Publication: 2020 Sep 16 (Print Publication: 2020).
